5th Annual EMBL Australia Postgraduate Symposium

Eadie, L. (Participant)

Acute Lymphoblastic Leukaemia Group

Activity: Other

Description

Tavakoli PS, Eadie LN, Heatley SL, White DL.
The dual SYK/JAK inhibitor cerdulatinib demonstrates in vitro efficacy against a novel MYB-TYK2 fusion protein in acute lymphoblastic leukaemia cells.
Oral and Poster Presentation
Brisbane, Queensland

Period	28 Nov 2018 → 30 Nov 2018